Key facts
- This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
- 8 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Mar 2025, 21:35.
Jonathan Sheena - 17 Mar 2025 Form 4 Insider Report for Natera, Inc. (NTRA)
- Reporting relationship
- Director, CO-FOUNDER
- Issuer ticker
- NTRA
- Reported as of
- 17 Mar 2025
- Net transaction value
- -$856,410
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2025, 21:35:14 UTC
- Prior SEC filing
- 14 Mar 2025
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tami Chen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 19 Mar 2025.
Change
- Previous filing in this sequence was filed on 14 Mar 2025.
- Current net transaction value: -$856,410.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NTRA
transaction
Common Stock
Sale
- Transaction value
- $26,431
- Shares
- -181
- Change %
- -0.07%
- Price
- $146.03
- Shares after
- 261,019
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
NTRA
transaction
Common Stock
Sale
- Transaction value
- $292,817
- Shares
- -2,017
- Change %
- -0.77%
- Price
- $145.17
- Shares after
- 259,002
- Date
- 18 Mar 2025
- Ownership
- Direct
- Footnotes
- F2, F3
NTRA
transaction
Common Stock
Sale
- Transaction value
- $7,717
- Shares
- -53
- Change %
- -0.02%
- Price
- $145.60
- Shares after
- 258,949
- Date
- 18 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
NTRA
transaction
Common Stock
Sale
- Transaction value
- $92,493
- Shares
- -630
- Change %
- -0.24%
- Price
- $146.81
- Shares after
- 258,319
- Date
- 18 Mar 2025
- Ownership
- Direct
- Footnotes
- F2, F4
NTRA
transaction
Common Stock
Sale
- Transaction value
- $155,251
- Shares
- -1,070
- Change %
- -2.5%
- Price
- $145.09
- Shares after
- 42,212
- Date
- 18 Mar 2025
- Ownership
- By Caraluna 1 Trust
- Footnotes
- F5, F6, F7
NTRA
transaction
Common Stock
Sale
- Transaction value
- $63,117
- Shares
- -430
- Change %
- -1%
- Price
- $146.78
- Shares after
- 41,782
- Date
- 18 Mar 2025
- Ownership
- By Caraluna 1 Trust
- Footnotes
- F5, F7, F8
NTRA
transaction
Common Stock
Sale
- Transaction value
- $146,664
- Shares
- -1,010
- Change %
- -2.3%
- Price
- $145.21
- Shares after
- 42,272
- Date
- 18 Mar 2025
- Ownership
- By Caraluna 2 Trust
- Footnotes
- F5, F7, F9
NTRA
transaction
Common Stock
Sale
- Transaction value
- $71,921
- Shares
- -490
- Change %
- -1.2%
- Price
- $146.78
- Shares after
- 41,782
- Date
- 18 Mar 2025
- Ownership
- By Caraluna 2 Trust
- Footnotes
- F5, F7, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 10 footnotes
Footnote F1
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 12, 2025.
Footnote F2
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
Footnote F3
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $147.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
Footnote F6
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F7
Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Footnote F8
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $146.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F9
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.67 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F10
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.40 to $146.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.